The Teófilo Hernando Foundation (FTH) and the Josep Carreras Leukaemia Research Institute (IJC) have signed a specific collaboration agreement to promote joint projects in clinical and biomedical research, as well as to strengthen their institutional cooperation.

The agreement recognises both organisations as collaborating entities and establishes a working framework aimed at optimising research, innovation and development of new medicines. The main areas of action include:

• Collaboration and advice support on clinical development projects, from preclinical stages to studies in humans.

• Identification and support in securing funding for strategic scientific initiatives.

• Creation of synergies and exchange forums, facilitating knowledge transfer, coordination between teams and the sharing of resources.

This collaboration with FTH is part of the Josep Carreras Institute's strategy to promote translational research, with the aim of accelerating the transformation of its scientific discoveries into innovative therapies for patients with blood cancers and advancing towards their cure, while consolidating its position as a leading centre in this mission.